Ebola in the Homeland: the Importance of Effective International, Federal, State, and Local Coordination

Total Page:16

File Type:pdf, Size:1020Kb

Ebola in the Homeland: the Importance of Effective International, Federal, State, and Local Coordination EBOLA IN THE HOMELAND: THE IMPORTANCE OF EFFECTIVE INTERNATIONAL, FEDERAL, STATE, AND LOCAL COORDINATION FIELD HEARING BEFORE THE COMMITTEE ON HOMELAND SECURITY HOUSE OF REPRESENTATIVES ONE HUNDRED THIRTEENTH CONGRESS SECOND SESSION OCTOBER 10, 2014 Serial No. 113–88 Printed for the use of the Committee on Homeland Security Available via the World Wide Web: http://www.gpo.gov/fdsys/ U.S. GOVERNMENT PUBLISHING OFFICE 93–646 PDF WASHINGTON : 2015 For sale by the Superintendent of Documents, U.S. Government Publishing Office Internet: bookstore.gpo.gov Phone: toll free (866) 512–1800; DC area (202) 512–1800 Fax: (202) 512–2104 Mail: Stop IDCC, Washington, DC 20402–0001 COMMITTEE ON HOMELAND SECURITY MICHAEL T. MCCAUL, Texas, Chairman LAMAR SMITH, Texas BENNIE G. THOMPSON, Mississippi PETER T. KING, New York LORETTA SANCHEZ, California MIKE ROGERS, Alabama SHEILA JACKSON LEE, Texas PAUL C. BROUN, Georgia YVETTE D. CLARKE, New York CANDICE S. MILLER, Michigan, Vice Chair BRIAN HIGGINS, New York PATRICK MEEHAN, Pennsylvania CEDRIC L. RICHMOND, Louisiana JEFF DUNCAN, South Carolina WILLIAM R. KEATING, Massachusetts TOM MARINO, Pennsylvania RON BARBER, Arizona JASON CHAFFETZ, Utah DONALD M. PAYNE, JR., New Jersey STEVEN M. PALAZZO, Mississippi BETO O’ROURKE, Texas LOU BARLETTA, Pennsylvania FILEMON VELA, Texas RICHARD HUDSON, North Carolina ERIC SWALWELL, California STEVE DAINES, Montana VACANCY SUSAN W. BROOKS, Indiana VACANCY SCOTT PERRY, Pennsylvania MARK SANFORD, South Carolina CURTIS CLAWSON, Florida BRENDAN P. SHIELDS, Staff Director JOAN O’HARA, Acting Chief Counsel MICHAEL S. TWINCHEK, Chief Clerk I. LANIER AVANT, Minority Staff Director (II) C O N T E N T S Page STATEMENTS The Honorable Michael T. McCaul, a Representative in Congress From the State of Texas, and Chairman, Committee on Homeland Security: Oral Statement ..................................................................................................... 1 Prepared Statement ............................................................................................. 4 The Honorable Bennie G. Thompson, a Representative in Congress From the State of Mississippi, and Ranking Member, Committee on Homeland Security: Oral Statement ..................................................................................................... 5 Prepared Statement ............................................................................................. 7 The Honorable Sheila Jackson Lee, a Representative in Congress From the State of Texas: Prepared Statement ............................................................................................. 8 WITNESSES PANEL I Dr. Toby Merlin, Director, Division of Preparedness and Emerging Infection, National Center for Emerging and Zoonotic Infectious Diseases, Centers for Disease Control and Prevention, U.S. Department of Health and Human Services: Oral Statement ..................................................................................................... 11 Prepared Statement ............................................................................................. 12 Dr. Kathryn Brinsfield, Acting Assistant Secretary and Chief Medical Officer, Office of Health Affairs, U.S. Department of Homeland Security: Oral Statement ..................................................................................................... 17 Joint Prepared Statement ................................................................................... 19 Mr. John Wagner, Acting Assistant Commisioner, Office of Field Operations, U.S. Customs and Border Protection, U.S. Department of Homeland Secu- rity: Oral Statement ..................................................................................................... 21 Joint Prepared Statement ................................................................................... 19 PANEL II Dr. David Lakey, Commissioner of Health, Texas Department of State Health Services: Oral Statement ..................................................................................................... 54 Prepared Statement ............................................................................................. 57 Dr. Brett P. Giroir, Executive Vice President and CEO, Texas A&M Health Science Center, and Director, Texas Task Force on Infectious Disease Pre- paredness and Response: Oral Statement ..................................................................................................... 60 Prepared Statement ............................................................................................. 61 Hon. Clay Lewis Jenkins, Judge, Dallas County, Texas: Oral Statement ..................................................................................................... 65 Prepared Statement ............................................................................................. 66 (III) IV Page Ms. Catherine L. Troisi, Ph.D., Associate Professor, Division of Management, Policy, and Community Health Center for Infectious Diseases, The Univer- sity of Texas: Oral Statement ..................................................................................................... 67 Prepared Statement ............................................................................................. 69 FOR THE RECORD The Honorable Michael T. McCaul, a Representative in Congress From the State of Texas, and Chairman, Committee on Homeland Security: Letter From Chairman Michael T. McCaul and Senator John Cornyn ........... 48 The Honorable Bennie G. Thompson, a Representative in Congress From the State of Mississippi, and Ranking Member, Committee on Homeland Security: Chart ..................................................................................................................... 7 The Honorable Sheila Jackson Lee, a Representative in Congress From the State of Texas: Press Release ........................................................................................................ 31 Chart ..................................................................................................................... 77 Letter from Rep. Jackson Lee to Director Frieden ............................................ 87 The Honorable Kenny Marchant, a Representative in Congress From the State of Texas: Letters ................................................................................................................... 46 APPENDIX Questions From Honorable Lamar Smith for Toby Merlin .................................. 93 Questions From Honorable Beto O’Rourke for Toby Merlin ................................ 93 Questions From Honorable Eric Swalwell for Toby Merlin ................................. 93 Questions From Honorable Lamar Smith for John P. Wagner ........................... 94 EBOLA IN THE HOMELAND: THE IMPOR- TANCE OF EFFECTIVE INTERNATIONAL, FEDERAL, STATE, AND LOCAL COORDINA- TION Friday, October 10, 2014 U.S. HOUSE OF REPRESENTATIVES, COMMITTEE ON HOMELAND SECURITY, Dallas, TX. The committee met, pursuant to call, at 12:10 p.m., in the In- Transit Lounge, D–31, Dallas-Fort Worth International Airport, 233 South International Drive, Dallas, Texas, Hon. Michael McCaul [Chairman of the committee] presiding. Present: Representatives McCaul, Chaffetz, Sanford, Clawson, Thompson, Jackson Lee, Barber, O’Rourke, Vela, and Swalwell. Also present: Representatives Farenthold, Marchant, Barton, Burgess, Veasey, and Johnson. Chairman MCCAUL. The Committee on Homeland Security will come to order. The committee is meeting today to examine the co- ordinated Federal, State, and local response to the recent Ebola case right here in Dallas, Texas. First, I want to thank everybody, including the witnesses, for attending this hearing today, and I ap- preciate the efforts taken on behalf of all those involved to have this important field hearing. This is an official Congressional hearing as opposed to a town hall, and as such, we must abide by certain rules of the committee and the House of Representatives. I would like to kindly remind our guests that demonstrations from the audience, including ap- plause and verbal outbursts, as well as the use of signs or placards are a violation of the rules of the House of Representatives, and it is important that we respect the decorum and the rules of this com- mittee. I have also been requested to state that photography and cameras are limited to accredited press only. Before I recognize myself for an opening statement, I also ask unanimous consent that the gentlemen from Texas, Mr. Joe Bar- ton, Mr. Michael Burgess, Mr. Kenny Marchant, Mr. Blake Farenthold, and Mr. Mark Veasey, and the gentlelady from Texas, Ms. Eddie Bernice Johnson, be permitted to sit on the dais and participate in today’s hearing. Without objection, so ordered. I will now recognize myself for an opening statement. We are here today to discuss the threat to the United States homeland from the Ebola virus and what is being done to stop the spread of this terrible disease. This crisis is unfolding at an alarm- ing pace. Thousands have died in Africa and thousands more have (1) 2 been infected, including four selfless Americans working in Liberia who have been flown home for treatment. Now the virus has begun to spread to other parts of the world, and the American people are rightfully concerned. They are con- cerned because the Ebola virus is an unseen threat, and it is only a plane flight away from our shores. We have witnessed that with the recent case here in Dallas, the first fatality
Recommended publications
  • Eradicating Ebola: Lessons Learned and Medical Advancements Hearing
    ERADICATING EBOLA: LESSONS LEARNED AND MEDICAL ADVANCEMENTS HEARING BEFORE THE SUBCOMMITTEE ON AFRICA, GLOBAL HEALTH, GLOBAL HUMAN RIGHTS, AND INTERNATIONAL ORGANIZATIONS OF THE COMMITTEE ON FOREIGN AFFAIRS HOUSE OF REPRESENTATIVES ONE HUNDRED SIXTEENTH CONGRESS FIRST SESSION JUNE 4, 2019 Serial No. 116–44 Printed for the use of the Committee on Foreign Affairs ( Available: http://www.foreignaffairs.house.gov/, http://docs.house.gov, or http://www.govinfo.gov U.S. GOVERNMENT PUBLISHING OFFICE 36–558PDF WASHINGTON : 2019 COMMITTEE ON FOREIGN AFFAIRS ELIOT L. ENGEL, New York, Chairman BRAD SHERMAN, California MICHAEL T. MCCAUL, Texas, Ranking GREGORY W. MEEKS, New York Member ALBIO SIRES, New Jersey CHRISTOPHER H. SMITH, New Jersey GERALD E. CONNOLLY, Virginia STEVE CHABOT, Ohio THEODORE E. DEUTCH, Florida JOE WILSON, South Carolina KAREN BASS, California SCOTT PERRY, Pennsylvania WILLIAM KEATING, Massachusetts TED S. YOHO, Florida DAVID CICILLINE, Rhode Island ADAM KINZINGER, Illinois AMI BERA, California LEE ZELDIN, New York JOAQUIN CASTRO, Texas JIM SENSENBRENNER, Wisconsin DINA TITUS, Nevada ANN WAGNER, Missouri ADRIANO ESPAILLAT, New York BRIAN MAST, Florida TED LIEU, California FRANCIS ROONEY, Florida SUSAN WILD, Pennsylvania BRIAN FITZPATRICK, Pennsylvania DEAN PHILLIPS, Minnesota JOHN CURTIS, Utah ILHAN OMAR, Minnesota KEN BUCK, Colorado COLIN ALLRED, Texas RON WRIGHT, Texas ANDY LEVIN, Michigan GUY RESCHENTHALER, Pennsylvania ABIGAIL SPANBERGER, Virginia TIM BURCHETT, Tennessee CHRISSY HOULAHAN, Pennsylvania GREG PENCE, Indiana
    [Show full text]
  • Nigeria MLA Replies to the Pandemic Response Questionnaire
    ANSWERS TO QUESTIONAIRE OF THE CMI ON PANDEMIC RESPONSE 1. Yes. 2. Yes. By virtue of the fact that Nigeria and some other 190 States did not make reservations to it. 3. Yes 4. Regulations have been made awaiting Ministerial Approval 5. Yes Came into force in Nigeria on 5th March, 1967 6. Attempts to implement the Convention have been made. However the full implementation is slowed down by several bureaucratic hiccups. 7. Yes. In the wake of the outbreak of Ebola, mild checks were put in place at entry points before grant of entrance especially for people from the Countries that had outbreak of Ebola 8. Yes. 9. (a) Nigeria adopted four major steps which had great impact in curtailing the spread of the Ebola Pandemic. They were: (i) Trace, Isolate, and Treat: Since it was confirmed that Ebola patients are not contagious until they exhibit symptoms such as fever, it was possible to adopt these strategies. Because, the source of Ebola into Nigeria was quickly traced to a Liberian American, Patrick Sawyer, who came to Nigeria in July 2014, Nigerian government/ health workers in charge could trace all the people that had contact, one way or the other, to Patrick Sawyer and the health personnel that had treated him or his contacts. In this wise, the victims’ close contacts were identified, isolated and they were educated about the symptoms. After a few lapses, proper medical protocol kept health care workers from getting sick. (ii) Early Detection before many people could be exposed: It is generally believed that anyone with Ebola, typically, will infect about two more people, unless something is done to intervene.
    [Show full text]
  • Impact of Ebola Virus Disease on School Administration in Nigeria
    American International Journal of Contemporary Research Vol. 5, No. 3; June 2015 Impact of Ebola Virus Disease on School Administration in Nigeria Oladunjoye Patrick, PhD Major, Nanighe Baldwin, PhD Niger Delta University Educational Foundations Department Wilberforce Island Bayelsa State Nigeria Abstract This study is focused on the impact of Ebola Virus Disease (EVD) on school administration in Nigeria. Two hypothesis were formulated to guide the study. A questionnaire titled Ebola Virus Disease and school administration (EVDSA) was used to collect data. The instrument was administered to one hundred and seventeen (117) teachers and eighty three (83) school administrators randomly selected from the three (3) regions in the federal republic of Nigeria. This instrument was however validated by experts and tested for reliability using the test re-test method and data analyzed using the Pearson Product Moment Correlation Coefficient. The result shows that there is a significant difference between teachers and school heads in urban and rural areas on the outbreak of the EVD. However, there is no significant difference in the perception of teachers and school heads in both urban and rural areas on the effect of EVD on attendance and hygiene in schools. Based on these findings, recommendations were made which include a better information system to the rural areas and the sustenance of the present hygiene practices in schools by school administrators. Introduction The school and the society are knitted together in such a way that whatever affects the society will invariably affect the school. When there are social unrest in the society, the school attendance may be affected.
    [Show full text]
  • Ebola Virus Disease October 2014 • $12.00 US
    SPECIAL DIGITAL ISSUE: Ebola Virus Disease October 2014 • $12.00 US EBOLA VIRUS DISEASE A Primer for Infection Preventionists Ebola Virus Disease: A Primer for Infection Preventionists By Kelly M. Pyrek ccording to the Centers for Disease Control and Prevention (CDC), Ebola — previously known as AEbola hemorrhagic fever — is a rare and deadly disease caused by infection with one of the Ebola virus strains. Ebola can cause disease in humans and non- human primates. Ebola is caused by infection with a virus of the family Filoviridae, genus Ebolavirus. There Ebola, previously known are five identified Ebola virus species, four of which are known to cause disease in humans: Ebola virus as Ebola hemorrhagic (Zaire ebolavirus); Sudan virus (Sudan ebolavirus); fever, is a rare and Taï Forest virus (Taï Forest ebolavirus, formerly Côte d’Ivoire ebolavirus); and Bundibugyo virus (Bundibugyo deadly disease caused ebolavirus). The fifth, Reston virus (Reston ebolavirus), by infection with one of has caused disease in non-human primates, but not in humans. the Ebola virus strains. Ebola was first discovered in 1976 near the Ebola River in what is now the Democratic Republic of the Congo. Since then, outbreaks have appeared sporadically in Africa. The natural reservoir host of Ebola virus remains unknown; however, on the basis of evidence and the nature of similar viruses, researchers believe that the virus is animal-borne and that bats are the most likely reservoir. Four of the five virus strains occur in an animal host native to Africa. INFECTION CONTROL TODAY Ebola Virus Disease www.infectioncontroltoday.com 3 The Outbreak Situation at Home and Abroad: An Update As of Oct.
    [Show full text]
  • Order Paper 5 November, 2019
    FOURTH REPUBLIC 9TH NATIONAL ASSEMBLY FIRST SESSION NO. 54 237 HOUSE OF REPRESENTATIVES FEDERAL REPUBLIC OF NIGERIA ORDER PAPER Tuesday 5 November, 2019 1. Prayers 2. National Pledge 3. Approval of the Votes and Proceedings 4. Oaths 5. Message from the President of the Federal Republic of Nigeria (if any) 6. Message from the Senate of the Federal Republic of Nigeria (if any) 7. Messages from Other Parliament(s) (if any) 8. Other Announcements (if any) 9. Petitions (if any) 10. Matter(s) of Urgent Public Importance 11. Personal Explanation ______________________________________________________________ PRESENTATION OF BILLS 1. Federal College of Agriculture, Katcha, Niger State (Establishment) Bill, 2019 (HB.403) (Hon. Saidu Musa Abdullahi) – First Reading. 2. Public Service Efficiency Bill, 2019 (HB.404) (Hon. Saidu Musa Abdullahi) – First Reading. 3. Constitution of the Federal Republic of Nigeria, 1999 (Alteration) Bill, 2019 (HB.405) (Hon. Saidu Musa Abdullahi) – First Reading. 4. Constitution of the Federal Republic of Nigeria, 1999 (Alteration) Bill, 2019 ((HB.406) (Hon. Dachung Musa Bagos) – First Reading. 5. National Rice Development Council Bill, 2019 (HB.407) (Hon. Saidu Musa Abdullahi) – First Reading. 238 Tuesday 5 November, 2019 No. 54 6. Constitution of the Federal Republic of Nigeria, 1999 (Alteration) Bill, 2019 (HB.408) (Hon. Dachung Musa Bagos) – First Reading. 7. Counselling Practitioners Council of Nigeria (Establishment) Bill, 2019 (HB.409) (Hon. Muhammad Ali Wudil) – First Reading. 8. Constitution of the Federal Republic of Nigeria, 1999 (Alteration) Bill, 2019 (HB.410) (Hon. Dachung Musa Bagos) – First Reading. 9. Federal University of Medicine and Health Services, Bida, Niger State (Establishment) Bill, 2019 (HB.411) (Hon.
    [Show full text]
  • What We Can Learn from and About Africa in the Corona Crisis The
    Pockets of effectiveness What we can learn from and about Africa in the corona crisis by Michael Roll, German Development Institute / D eutsches Institut für Entwicklungspolitik (DIE) The Current Column of 2 April 2020 Pockets of effectiveness What we can learn from and about Africa in the corona crisis Is Africa defenceless in the face of the corona pandemic? This to a treatment centre. In total, 20 people became infected in would appear to be self-evident, as even health care systems Nigeria in 2014 and eight of them died. The WHO lauded the far better equipped than those of many African countries are successful contact-tracing work under very difficult condi- currently on the verge of collapse. Nonetheless, such a con- tions as a piece of “world-class epidemiological detective clusion is premature. In part, some African countries are work”. even better prepared for pandemics than Europe and the What does this mean for corona in Nigeria and in Africa? As a United States. Nigeria’s success in fighting its 2014 Ebola result of their experience with infectious diseases, many Afri- outbreak illustrates why that is the case and what lessons can countries have established structures for fighting epidem- wealthier countries and the development cooperation com- ics in recent years. These measures and the continent’s head munity can learn from it. start over other world regions are beneficial for tackling the Learning from experience corona pandemic. However, this will only help at an early stage when the chains of infection can still be broken by iden- Like other African countries, Nigeria has experience in deal- tifying and isolating infected individuals.
    [Show full text]
  • BY the TIME YOU READ THIS, WE'll ALL BE DEAD: the Failures of History and Institutions Regarding the 2013-2015 West African Eb
    Trinity College Trinity College Digital Repository Senior Theses and Projects Student Scholarship Spring 2015 BY THE TIME YOU READ THIS, WE’LL ALL BE DEAD: The failures of history and institutions regarding the 2013-2015 West African Ebola Pandemic. George Denkey Trinity College, [email protected] Follow this and additional works at: https://digitalrepository.trincoll.edu/theses Part of the African Languages and Societies Commons, International Public Health Commons, and the International Relations Commons Recommended Citation Denkey, George, "BY THE TIME YOU READ THIS, WE’LL ALL BE DEAD: The failures of history and institutions regarding the 2013-2015 West African Ebola Pandemic.". Senior Theses, Trinity College, Hartford, CT 2015. Trinity College Digital Repository, https://digitalrepository.trincoll.edu/theses/517 BY THE TIME YOU READ THIS, WE’LL ALL BE DEAD: The failures of history and institutions regarding the 2013-2015 West African Ebola Pandemic. By Georges Kankou Denkey A Thesis Submitted to the Department Of Urban Studies of Trinity College in partial fulfillment of the requirements for the Bachelor of Arts Degree 1 Table Of Contents For Ameyo ………………………………………………..………………………........ 3 Abstract …………………………………………………………………………………. 4 Acknowledgments ………………………………………………………………………. 5 Introduction ……………………………………………………………………………… 6 Ebola: A Background …………………………………………………………………… 20 The Past is a foreign country: Historical variables behind the spread ……………… 39 Ebola: The Detailed Trajectory ………………………………………………………… 61 Why it spread: Cultural
    [Show full text]
  • Review Article Ebola Virus Disease
    International Journal of Nursing Research (IJNR) International Peer Reviewed Journal Review article Ebola virus disease: Comprehensive review Archana R. Dhanawade Bharati Vidyapeeth Deemed University College of Nursing,, Sangli, Maharashtra, India Abstract Ebola is a Filoviridae virus with characteristic filamentous structure of a thread virus. It became a global threat when its outbreak has affected lives of thousands of people including doctors, nursing staff, healthcare workers. The virus spreads via direct contact with blood or body fluids from an infected person in an uncontrolled manner with limited treatment options. The Ebola virus disease is a very serious health problem causing major deaths within a short period. As there are no specific treatment or vaccines available, prevention is the only option to control the spread of disease. So, the health team members, the staff nurses who are more prone to this disease should have adequate knowledge about the disease and its prevention to handle the situation. Keywords: Ebola Virus Disease, nursing, health problem *Corresponding author: Archana R. Dhanawade, Bharati Vidyapeeth Deemed University College of Nursing,, Sangli, Maharashtra, India, India. Email: [email protected] 1. Introduction of Ebola virus disease months later the second outbreak of Ebola virus emerged from Zaire with highest mortality rate The recent outbreak of Ebola Virus Disease (EVD) infecting 318 people. In spite of tremendous has revealed many weaknesses in the public efforts of experienced and dedicated researchers, healthcare system in controlling the spread of Ebola’s natural reservoir was not identified. The disease. In addition, the outbreak has affected third outbreak of Ebola was identified in 1989 lives of thousands of people including doctors, when infected monkeys were imported into nursing staff and healthcare workers [1].
    [Show full text]
  • Learning from Ebola: How Drug-Development Policy Could Help Stop Outbreaks of Infectious Diseases*
    Learning from Ebola: How Drug-Development Policy Could Help Stop Outbreaks of Infectious Diseases* William W. Fisher III** and Katrina Geddes*** Version 3.2; October 14, 2015 Between 2013 and 2015, an outbreak of Ebola Hemorrhagic Fever killed more than 11,000 people and devastated three countries in western Africa. Preventing or limiting similar outbreaks in the future will require public-health initiatives of many sorts. This essay examines one such initiative that has thus far received little attention: modification of the policies used by governments and nongovernmental organizations to shape the development and distribution of pharmaceutical products aimed at infectious diseases. Part I of the paper summarizes the epidemiology of Ebola and the history of the recent outbreak. Part II considers the potential role of vaccines and medicines in combating Ebola and why we have thus far failed to develop them. Part III describes the various research projects provoked by the recent outbreak. Part IV considers several ways in which our drug development policies might be altered – either fundamentally or incrementally – that could strengthen the portfolio of ongoing research projects and reduce the incidence or severity of similar outbreaks in the future. I. Background The Ebola virus (EBOV) is an aggressive pathogen that causes a hemorrhagic shock syndrome in infected humans. Symptoms of that syndrome include fever, headache, fatigue, vomiting, gastrointestinal bleeding, rash, coagulation abnormalities, and a range of hematological irregularities such as lymphopenia (abnormally low levels of lymphocytes) and neutrophilia (abnormally high levels of neutrophil granulocytes).1 These symptoms typically first appear 8 to 10 days after exposure to the virus.2 If untreated, they usually result in death * An early draft of this paper was prepared for a workshop, hosted by Global Access in Action, held at Harvard University on July 10, 2015.
    [Show full text]
  • Resident's Roles in the Optimization of the Preparedness Protocols For
    1 Article 2 Resident’s roles in the optimization of the preparedness 3 protocols for Ebola pandemic in urban environment 4 Analysis of Residents’ preparedness protocols during Ebola 5 pandemic in urban environment 6 7 Emmanuel O. Amoo 1,*, Gbolahan A. Oni 1, Aize Obayan 2,3, Amos Alao 3, Olujide Adekeye 3, Gbemisola Samuel 1, 8 Samuel A. Oyegbile 4 and Evaristus Adesina 9 1 Demography and Social Statistics, College of Business and Social Sciences, Covenant University, Ota, Ogun 10 State, Nigeria. 11 2 African Leadership Development Centre, Covenant University, Canaanland, Ota, Ogun State, Nigeria. 12 3 Department of Psychology, College of Leadership and Development Studies, Covenant University, Canaan- 13 land, Ota, Ogun State, Nigeria. 14 4 Health Peak Medical Centre, 21 Ibido Street, Agege, Lagos State, Nigeria. 15 * Correspondence: [email protected] 16 Abstract: Background: The study provided empirical analysis of the Citation: Amoo, E.O.; Oni, G.; 17 change in hygiene behavioural practices among community in Obayan, A.; Alao, A.; Adekeye, O.; 18 Ogun and Lagos State with respect to Ebola outbreak in Nigeria. The study Samuel, G.; Oyegbile, S.A.; Adesina, 19 assessed men’s role in the preparedness against emerging pandemic of Ebola Virus Disease in Ogun E. Resident’s roles in the optimiza- tion of the preparedness protocols 20 State, Nigeria. It examined the changes in men’s hygiene practices as response to the news of the for Ebola pandemic in urban envi- 21 outbreak of Ebola Virus Disease (EVD). Methods: The data were extracted from a 2015 Cross-Sec- ronment. Sustainability 2021, 13, x.
    [Show full text]
  • Understanding Ebola: the 2014 Epidemic Jolie Kaner1,2 and Sarah Schaack2*
    Kaner and Schaack Globalization and Health (2016) 12:53 DOI 10.1186/s12992-016-0194-4 REVIEW Open Access Understanding Ebola: the 2014 epidemic Jolie Kaner1,2 and Sarah Schaack2* Abstract Near the end of 2013, an outbreak of Zaire ebolavirus (EBOV) began in Guinea, subsequently spreading to neighboring Liberia and Sierra Leone. As this epidemic grew, important public health questions emerged about how and why this outbreak was so different from previous episodes. This review provides a synthetic synopsis of the 2014–15 outbreak, with the aim of understanding its unprecedented spread. We present a summary of the history of previous epidemics, describe the structure and genetics of the ebolavirus, and review our current understanding of viral vectors and the latest treatment practices. We conclude with an analysis of the public health challenges epidemic responders faced and some of the lessons that could be applied to future outbreaks of Ebola or other viruses. Keywords: Ebola, Ebolavirus, 2014 outbreak, Epidemic, Review Abbreviations: BEBOV, Bundibugyo ebolavirus;CIEBOV,Côte d’Ivoire ebolavirus;EBOV,Ebolavirus; EVD, Ebola virus disease or Ebola; Kb, Kilobase; MSF, Médecins Sans Frontières; REBOV, Reston ebolavirus; SEBOV, Sudan ebolavirus;WHO,World Health Organization; ZEBOV, Zaire ebolavirus Background NP (nucleoprotein), VP35 (polymerase cofactor), VP40 As of April 13th, 2016 there have been 28,652 total cases (matrix protein), GP (glycoprotein), VP30 (transcrip- of Ebola virus disease (EVD; or more generally Ebola) in tion activator), VP24 (secondary matrix protein), and the 2014–2015 West African epidemic [1]. Of these, RNA-dependent RNA polymerase [6]. There are currently 11,325 cases (40 %) were fatal [1].
    [Show full text]
  • Texas Ebola Patient Gets Experimental Drug (Update) 6 October 2014, by Kerry Sheridan
    Texas Ebola patient gets experimental drug (Update) 6 October 2014, by Kerry Sheridan A Liberian man diagnosed with Ebola in Texas was fellow heads of state and government around the given an experimental drug for the first time, world to make sure that they are doing everything officials said Monday as the White House mulled that they can to join us in this effort." tougher airport screening at home and abroad. He said the United States is considering tougher Thomas Eric Duncan was given the investigational airport screening to ward against the spread of medication, brincidofovir, on Saturday, the day his cases by airline travelers. condition worsened from serious to critical, said Texas Health Presbyterian Hospital Dallas. "We're also going to be working on protocols to do additional passenger screening both at the source The medication is made by the North Carolina- and here in the United States," Obama told based pharmaceutical company Chimerix, and until reporters. now had never been tried in humans with Ebola, the company said. In Nebraska, a US photojournalist who tested positive for Ebola in Liberia arrived at a hospital However, it has been tested in about 1,000 people and was able to walk off the airplane that carried against adenovirus and cytomegalovirus. him. The drug "works by keeping viruses from creating "We are really happy that his symptoms are not additional copies of themselves," Chimerix said. extreme yet," Ashoka Mukpo's mother, Diana, told reporters, adding that he was feverish and Duncan is the first person to be diagnosed with nauseous. Ebola in the United States, and he is believed to have become infected while in Liberia.
    [Show full text]